311 related articles for article (PubMed ID: 35855345)
1. Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update.
Yu CC; Du YJ; Li J; Li Y; Wang L; Kong LH; Zhang YW
Aging Dis; 2022 Jul; 13(4):1092-1105. PubMed ID: 35855345
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of puerarin against cerebral diseases: From bench to bedside.
Liu T; Su K; Cai W; Ao H; Li M
Eur J Pharmacol; 2023 Aug; 953():175695. PubMed ID: 36977450
[TBL] [Abstract][Full Text] [Related]
3. Puerarin: a review of pharmacological effects.
Zhou YX; Zhang H; Peng C
Phytother Res; 2014 Jul; 28(7):961-75. PubMed ID: 24339367
[TBL] [Abstract][Full Text] [Related]
4. Puerarin: a potential natural neuroprotective agent for neurological disorders.
Liu X; Huang R; Wan J
Biomed Pharmacother; 2023 Jun; 162():114581. PubMed ID: 36966665
[TBL] [Abstract][Full Text] [Related]
5. Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases.
Chauhan P; Wadhwa K; Mishra R; Gupta S; Ahmad F; Kamal M; Iqbal D; Alsaweed M; Nuli MV; Abomughaid MM; Almutary AG; Mishra PC; Jha SK; Ojha S; Nelson VK; Dargar A; Singh G; Jha NK
Mol Neurobiol; 2024 May; ():. PubMed ID: 38780722
[TBL] [Abstract][Full Text] [Related]
6. Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases.
Bai X; Fu RJ; Zhang S; Yue SJ; Chen YY; Xu DQ; Tang YP
Biomed Pharmacother; 2021 Jul; 139():111551. PubMed ID: 33865016
[TBL] [Abstract][Full Text] [Related]
7. Puerarin: A protective drug against ischemia-reperfusion injury.
Gao M; Zhang Z; Lai K; Deng Y; Zhao C; Lu Z; Geng Q
Front Pharmacol; 2022; 13():927611. PubMed ID: 36091830
[TBL] [Abstract][Full Text] [Related]
8. Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata.
Chen X; Yu J; Shi J
Am J Chin Med; 2018; 46(8):1771-1789. PubMed ID: 30525896
[TBL] [Abstract][Full Text] [Related]
9. Protective effects and mechanism of puerarin targeting PI3K/Akt signal pathway on neurological diseases.
Wang Q; Shen ZN; Zhang SJ; Sun Y; Zheng FJ; Li YH
Front Pharmacol; 2022; 13():1022053. PubMed ID: 36353499
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Methods of Puerarin Biotransformation.
Liu G; Liu Z; Yuan S
Mini Rev Med Chem; 2016; 16(17):1392-1402. PubMed ID: 27145856
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Activity, Pharmacokinetics, and Clinical Research Progress of Puerarin.
Wang D; Bu T; Li Y; He Y; Yang F; Zou L
Antioxidants (Basel); 2022 Oct; 11(11):. PubMed ID: 36358493
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effects of Curcumin in Cerebral Ischemia: Cellular and Molecular Mechanisms.
Subedi L; Gaire BP
ACS Chem Neurosci; 2021 Jul; 12(14):2562-2572. PubMed ID: 34251185
[TBL] [Abstract][Full Text] [Related]
13. The neuritogenic and synaptogenic effects of the ethanolic extract of radix Puerariae in cultured rat hippocampal neurons.
Haque Bhuiyan MM; Mohibbullah M; Hannan MA; Hong YK; Han CH; Kim YK; Moon IS
J Ethnopharmacol; 2015 Sep; 173():172-82. PubMed ID: 26196403
[TBL] [Abstract][Full Text] [Related]
14. The neuroprotective mechanism of puerarin in the treatment of acute spinal ischemia-reperfusion injury is linked to cyclin-dependent kinase 5.
Tian F; Xu LH; Wang B; Tian LJ; Ji XL
Neurosci Lett; 2015 Jan; 584():50-5. PubMed ID: 25301568
[TBL] [Abstract][Full Text] [Related]
15. The in silico and in vivo evaluation of puerarin against Alzheimer's disease.
Liu S; Cao XL; Liu GQ; Zhou T; Yang XL; Ma BX
Food Funct; 2019 Feb; 10(2):799-813. PubMed ID: 30675620
[TBL] [Abstract][Full Text] [Related]
16. Comparative Pharmacokinetic Profiles of Puerarin in Rat Plasma by UHPLC-MS/MS after Oral Administration of
Zhang G; Ji J; Sun M; Ji Y; Ji H
J Anal Methods Chem; 2020; 2020():4258156. PubMed ID: 32351754
[TBL] [Abstract][Full Text] [Related]
17. Triptolide with potential medicinal value for diseases of the central nervous system.
Zheng Y; Zhang WJ; Wang XM
CNS Neurosci Ther; 2013 Feb; 19(2):76-82. PubMed ID: 23253124
[TBL] [Abstract][Full Text] [Related]
18. Progress on the pharmacological research of puerarin: a review.
Wei SY; Chen Y; Xu XY
Chin J Nat Med; 2014 Jun; 12(6):407-14. PubMed ID: 24969520
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice.
Zhu G; Wang X; Wu S; Li X; Li Q
Phytother Res; 2014 Feb; 28(2):179-86. PubMed ID: 23512787
[TBL] [Abstract][Full Text] [Related]
20. [Pharmaceutics research advances in oral administration of puerarin].
Wu WT; Zou B; Li WD; Zhu WF
Zhongguo Zhong Yao Za Zhi; 2019 Oct; 44(19):4134-4141. PubMed ID: 31872690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
